<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01062126</url>
  </required_header>
  <id_info>
    <org_study_id>CRD525</org_study_id>
    <nct_id>NCT01062126</nct_id>
  </id_info>
  <brief_title>BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes</brief_title>
  <acronym>BRADYCARE</acronym>
  <official_title>Advanced Bradycardia Device Feature Utilization and Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have&#xD;
      been made in pacemaker therapy, diagnostics and connectivity. These advancements include&#xD;
      automated capture, automated sensing, patient alert functions, algorithms minimizing&#xD;
      ventricular pacing, automatic mode switching in response to atrial tachyarrhythmia, rate&#xD;
      responsive pacing, advanced diagnostic features, remote monitoring and radiofrequency (RF)&#xD;
      technology. However, little information is available on how these new features are being&#xD;
      utilized by physicians in the real world and how these features impact patient outcomes.&#xD;
&#xD;
      This observational study will gather data on the patients' presenting clinical status,&#xD;
      indication for device implantation, utilization of advanced device features, device therapy&#xD;
      choices, clinical management and outcomes in a general pacemaker population.&#xD;
&#xD;
      The primary aim of the study is to evaluate the usage of advanced features and diagnostics in&#xD;
      patients with St. Jude Medical pacemakers. The secondary aim of the study is to learn more&#xD;
      about the progressive clinical outcomes in the general pacemaker patient population. The&#xD;
      tertiary aim of the study is to evaluate the correlation between the usage of advanced&#xD;
      features in pacemaker patients and the patient's clinical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of Device Features and Diagnostics&#xD;
&#xD;
        -  Programmed parameters: Advanced pacemaker features (Autocapture, Auto sensitivity&#xD;
           control (ASC), Ventricular Intrinsic Preference (VIP®), Patient Notifier, RF telemetry,&#xD;
           and newer advanced features)&#xD;
&#xD;
        -  Device and lead measurements&#xD;
&#xD;
        -  Number of AT/AF, VT/VF, PMT and AMS episodes&#xD;
&#xD;
      Evaluation of Clinical Parameters&#xD;
&#xD;
        -  Indication for device implantation&#xD;
&#xD;
        -  Cardiac and arrhythmia history&#xD;
&#xD;
        -  Cardiac drug utilization&#xD;
&#xD;
        -  Cardiac events: incidence and onset of symptomatic atrial fibrillation (AF), onset of&#xD;
           heart failure (HF), incidence and onset of angina, occurrence of myocardial infarction&#xD;
           (MI), occurrence of transient ischemic attack (TIA)/ischemic stroke, and occurrence of&#xD;
           hemorrhagic stroke&#xD;
&#xD;
        -  Modified Specific Activity Scale (SAS)&#xD;
&#xD;
        -  Intrinsic QRS duration&#xD;
&#xD;
        -  Left ventricular ejection fraction (LVEF)&#xD;
&#xD;
        -  Adverse events&#xD;
&#xD;
        -  All-cause, cardiovascular and heart failure hospitalizations&#xD;
&#xD;
        -  All-cause, cardiovascular and heart failure mortality&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complication Rate at 1-year Post-implant</measure>
    <time_frame>12 months</time_frame>
    <description>Complication rate and 95% confidence interval at 1-year post-implant</description>
  </primary_outcome>
  <enrollment type="Actual">3389</enrollment>
  <condition>Pacemaker</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for standard Pacemaker indications&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has a current indication for a single-chamber (SR) or dual-chamber (DR)&#xD;
             pacemaker or CRT-P device.&#xD;
&#xD;
          -  Patient is implanted with an SJM Accent™ SR/DR, Accent™ SR/DR RF, Anthem™ CRT-P,&#xD;
             Anthem™ CRT-P RF, or newer SJM pacemaker device.&#xD;
&#xD;
          -  Patient is geographically stable and willing to comply with the required follow-up&#xD;
             schedule.&#xD;
&#xD;
          -  Patient is not pregnant or planning to become pregnant.&#xD;
&#xD;
          -  Patient is &gt;18 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's life expectancy is less than 12 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grant Kim</last_name>
    <role>Study Director</role>
    <affiliation>Abbott (previously St. Jude Medical)</affiliation>
  </overall_official>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 2, 2010</study_first_submitted>
  <study_first_submitted_qc>February 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2010</study_first_posted>
  <results_first_submitted>October 7, 2019</results_first_submitted>
  <results_first_submitted_qc>September 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 14, 2020</results_first_posted>
  <last_update_submitted>September 22, 2020</last_update_submitted>
  <last_update_submitted_qc>September 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pacemaker</keyword>
  <keyword>Advanced Features</keyword>
  <keyword>Clinical Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Subjects Enrolled in the Study</title>
          <description>Patients implanted with an SJM Accent SR/DR, Accent SR/DR RF, Anthem CRT-P, Anthem CRT-P RF, or newer SJM pacemaker device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3389"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2856"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="533"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>All Withdrawals</title>
              <participants_list>
                <participants group_id="P1" count="324"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Subjects Enrolled in the Study</title>
          <description>All subjects that were enrolled in the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3389"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="559"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2830"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.8" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1546"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1843"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="185"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3175"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3389"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Indication for Pacemaker Implant</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Sinus Node Dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2427"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AV Node Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pacemaker Replacement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PAVE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Others</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiovascular History</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Coronary Artery Disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1361"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myocardial Infarction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2668"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ejection Fraction</title>
          <units>% of blood leaving heart at contraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.8" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Other Medical History</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Pulmonary disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hepatic/Renal disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="869"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peripheral vascular disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ACE Inhibitors/ARBs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1659"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aldosterone inhibitors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-coagulants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1064"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiarrhythmics - Class I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiarrhythmics - Class III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiplatelet</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1833"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Beta Blockers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1653"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium channel blockers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="936"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiac glycosides</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diuretics</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nitrates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other cardiac</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="351"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Ionotropics</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Statins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic BP</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130.1" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic BP</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.2" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Rate</title>
          <units>beats per min (bpm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.4" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Complication Rate at 1-year Post-implant</title>
        <description>Complication rate and 95% confidence interval at 1-year post-implant</description>
        <time_frame>12 months</time_frame>
        <population>All subjects enrolled in the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects Enrolled in the Study</title>
            <description>All subjects that were enrolled in the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Complication Rate at 1-year Post-implant</title>
          <description>Complication rate and 95% confidence interval at 1-year post-implant</description>
          <population>All subjects enrolled in the study.</population>
          <units>percentage of enrolled subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3389"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" lower_limit="0.8" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events reported during the 1-year study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>All Subjects Enrolled in the Study</title>
          <description>All subjects that were enrolled in the study.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding/Hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Dehisence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Mid-sternal pain at the location of RA and RV leads</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Open wound at PG incision site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Pericardial tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Pocket Revision- not Healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Set Screw not secured at Implant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Lead dislodgement or migration</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Elevated pacing thresholds</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Diaphragmatic/Phrenic Nerve Stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Lead Malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Lead fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Loss of capture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Oversensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.05</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Elevated pacing thresholds</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Oversensing</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Inappropriate device interaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Loss of capture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3389"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3389"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Grant Kim</name_or_title>
      <organization>Abbott (Previously St Jude Medical)</organization>
      <phone>818-493-3147</phone>
      <email>grant.kim1@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

